AN
Anuh Pharma Ltd (ANUHPHR)
₹79.28
Mkt cap
₹810 Cr
P/E ratio
17.00
P/B
2.21
Div yield
1.86%
ROE
11.30%
ROCE
14.90%
EPS (TTM)
₹4.66
Book value
₹36
52W range
67–100
Sector
Healthcare
Price history
Previous close
Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals [1]
NSE ANUHPHRBSE 506260
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−20.32% from high₹79
₹67+18.33% from low₹100
Current
₹79.28
Prev close
₹79.76
Day
−0.60%
Price performance
1D
−0.85%
1W
−4.09%
1M
+0.27%
3M
+4.18%
6M
+3.82%
1Y
−2.67%
YTD
−1.15%
Financials
Revenue, profit & margin
P/E ratio
17.0×
ANUHPHR is 49% below the sector median of 33.4×
ANUHPHR17.0×
Sector median33.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 172 | 164 | 138 | 166 | 160 | 198 | 186 | 186 | 197 | 202 | 194 | 185 | |
| YoY Sales growth | +30% | +24% | +4% | -15% | +11% | -7% | +21% | +35% | +12% | +24% | +2% | +4% | -0% | |
| Expenses | 132 | 148 | 145 | 127 | 149 | 145 | 179 | 176 | 174 | 178 | 182 | 178 | 168 | |
| Operating Profit | 18 | 24 | 19 | 11 | 17 | 15 | 19 | 10 | 12 | 19 | 20 | 16 | 17 | |
| OPM % | 12% | 14% | 12% | 8% | 10% | 9% | 9% | 6% | 6% | 10% | 10% | 8% | 9% | |
| Other Income | 2 | 4 | 3 | 4 | 3 | 1 | 1 | 3 | 1 | 2 | -1 | 3 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | |
| Profit before tax | 18 | 25 | 20 | 12 | 18 | 13 | 17 | 11 | 10 | 18 | 16 | 17 | 15 | |
| Tax % | 23% | 24% | 22% | 22% | 17% | 22% | 28% | 24% | 23% | 25% | 25% | 32% | 25% | |
| Net Profit | 14 | 19 | 15 | 10 | 15 | 10 | 12 | 8 | 8 | 13 | 12 | 11 | 11 | |
| EPS in Rs | 1.38 | 1.91 | 1.53 | 0.95 | 1.50 | 1.03 | 1.24 | 0.83 | 0.76 | 1.34 | 1.17 | 1.14 | 1.12 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202671.79%Promoter
Promoters71.79%
FIIs0.11%0.10
DIIs0.00%
Public28.07%0.12
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,870.00 | 36.46 | 4,48,676 | 0.86% | 1,995 | −10.53% | 16,199 | +11.88% | 20.53% |
| Divi's Lab. | ₹11,150.00 | 86.62 | 2,95,997 | 0.27% | 1,127 | +63.57% | 3,676 | +35.40% | 21.97% |
| Torrent Pharma. | ₹4,668.80 | 81.80 | 1,77,586 | 0.81% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,338.00 | 94.28 | 1,26,325 | 0.09% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,204.20 | 26.51 | 1,20,119 | 0.08% | 928 | −27.96% | 7,910 | +29.17% | 21.14% |
| Dr Reddy's Labs | ₹1,388.00 | 41.41 | 1,15,936 | 0.58% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,388.00 | 36.11 | 1,12,135 | 0.94% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Anuh Pharma | ₹80.77 | 16.95 | 810 | 1.86% | 11 | +47.31% | 185 | −0.34% | 14.94% |
| Median: 160 Co. | ₹445.73 | 33.35 | 2,016 | 0.08% | 13 | +33.73% | 179 | +21.23% | 14.94% |
Filings
Annual reports15
Concall transcripts35
Credit ratings6
Announcements5
Announcement Under Regulation 30 (LODR) - Capacity Addition 15 Nov - Anuh Pharma inaugurated Tarapur plant on 15 Nov 2026; capacity rises by 525 MT to 2,925 MT annually.Announcement Under Regulation 30 (LODR) - Inauguration Of Manufacturing Facility F-10/1 And Commencement Of Commercial Production Of The Company. 15 Nov - Anuh Pharma inaugurated F-10/1 Tarapur plant; 525 MT/year capacity to be added by December 2026.Announcement under Regulation 30 (LODR)-Investor Presentation 6 Nov - Investor Presentation for Q2 and H1 FY 2026-27Announcement under Regulation 30 (LODR)-Newspaper Publication 1 Nov - Newspaper Publication of the Unaudited Financial Results for the Quarter and half year ended 30th September, 2026, published in the Financial Express in English Language …Announcement Under Regulation 30 (LODR) - Intimation Regarding The Request Received For Withdrawal Of Application For Reclassification. 30 Oct - Nina Vijay Shah withdrew reclassification request; remains in Promoter Group.






